تحليلات المنتج الاختيارية
بإذنك، نستخدم تحليلات محدودة تراعي الخصوصية لفهم مسارات البحث الفعالة. لا نستخدم أدوات تتبع إعلانية أو تسجيل الجلسات. يمكنك تغيير هذا الخيار في التفضيلات. اقرأ سياسة الخصوصية.
The Procter & Gamble Company's published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $340.1B | |
|---|---|---|
| Revenue (ttm) | 87.9B | |
| Net income (ttm) | 15.7B | |
| EPS (ttm) | $6.64 | |
| Shares out | 2.3B | |
| P/E (trailing) | 23.9x | |
| P/E (forward) | 21.1x | |
| Dividend | $4.35 (2.75%) | |
| Volume | 3,382,574 | |
| Beta | 0.38 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2026-06-30 | Trend |
| Revenue | $80.19B | $82.01B | $84.04B | $84.28B | $87.03B | +2.1% |
| Gross profit | $38.03B | $39.25B | $43.19B | $43.12B | $43.67B | +3.5% |
| Operating income | $17.81B | $18.13B | $18.55B | $20.45B | $19.75B | +2.6% |
| Net income | $14.74B | $14.65B | $14.88B | $15.97B | $16.05B | +2.1% |
| EPS (diluted) | $5.81 | $5.90 | $6.02 | $6.51 | $6.62 | +3.3% |
| EBITDA | $21.24B | $21.77B | $22.58B | $23.92B | $21.25B | +0.0% |
| R&D | $2.00B | $2.00B | $2.00B | $2.10B | $2.10B | +1.2% |
| SG&A | $20.22B | $21.11B | $23.31B | $22.67B | $23.92B | +4.3% |
Recent company headlines from major financial publishers.
The base case is modest compounding, not a sharp reacceleration. A miss against either annual revenue anchor would disconfirm it by FY2028.
Upside requires FY2028 earnings to meet the forecast, FY2026 cash generation to persist, and the FY2024-to-FY2026 decline in diluted shares to continue. A miss against the FY2028 forecast or weaker operating cash would disconfirm this path.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.0% | $151 | $163 | $180 | $204 | $244 |
| 6.0% | $131 | $138 | $146 | $158 | $173 |
| 7.0% | $117 | $121 | $126 | $133 | $141 |
| 8.0% | $107 | $110 | $113 | $117 | $122 |
| 9.0% | $99.4 | $102 | $104 | $107 | $110 |
Upcoming earnings date and setup when available.
التصنيف الذي حملته نسخة البحث المنشورة في كل شهر. يقارن التصنيف السعر في تاريخ التحليل بالقيمة العادلة، وليس سجلاً لمدى صحة التقدير.
| السنة | يناير | فبراير | مارس | أبريل | مايو | يونيو | يوليو | أغسطس | سبتمبر | أكتوبر | نوفمبر | ديسمبر |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
